Form 4: Ginkgo Bioworks Director Shyam Sankar Buys $514,750 Worth of Shares

Director Shyam Sankar of Ginkgo Bioworks Holdings, Inc. recently purchased 625,000 shares of Class A Common Stock at an average price of $0.8236 per share.

Summary

• On May 15, 2024, Shyam Sankar, a director of Ginkgo Bioworks Holdings, Inc., acquired 625,000 shares of Class A Common Stock.
• The shares were purchased at a weighted average price of $0.8236, with individual prices ranging from $0.8118 to $0.8349.
• Following the transaction, Sankar directly owns 2,356,874 shares of Ginkgo Bioworks' Class A Common Stock.

Sentiment

Score: 7

Explanation: Insider buying is generally viewed as a positive sign, suggesting confidence in the company's future. The size of the purchase is significant, further boosting the sentiment.

Positives

• A director's purchase of a significant number of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. It can be compared to other insider transactions within the biotechnology sector to gauge overall sentiment.

Comparison to Industry Standards

• Comparing this insider purchase to similar transactions at companies like Amyris or Zymergen (prior to its acquisition) could provide context.
• Analyzing the size of the purchase relative to Sankar's existing holdings and the company's market capitalization offers further insight.
• Benchmarking against industry averages for insider buying activity can help determine if this transaction is particularly noteworthy.

Stakeholder Impact

• The purchase could positively influence shareholder sentiment.
• It may also boost employee morale by signaling confidence from a company director.

Key Dates